In colorectal cancer, as in metastatic urothelial cancer, the blockade of TGFβ signaling increased tumor sensitivity to anti-PD-L1 by facilitating T lymphocyte infiltration [283,284]. The gene discussed is TGFB1; the disease is colorectal cancer.